OR WAIT null SECS
August 18, 2025
Podcast
Cohosts Stephen Greene, MD, and Muthiah Vaduganathan, MD, MPH, sit down with Darren McGuire, MD, to discuss the results of this groundbreaking trial.
This episode includes a breakdown of topline data from ATTAIN-1 and part 1 of the recap for ADCES 2025.
August 11, 2025
Article
Despite obesity’s well-known influence on AF recurrence, neither comorbidity has a significant influence on outcomes from early rhythm control therapy.
August 08, 2025
Discover key advancements in endocrinology from July 2025, including FDA approvals and trial results.
Cafraglutide was effective with less frequent dosing than currently available medications that target GLP-1.
August 07, 2025
The once-daily oral GLP-1 RA met the primary endpoint for body weight reduction at 72 weeks and demonstrated improvements in cardiovascular risk factors.
August 05, 2025
Hosts offer perspective on the topline results from SURPASS-CVOT and what the cardiovascular data on tirzepatide means for care.
July 29, 2025
New data revealed that sleep impairment, especially daytime dysfunction, short duration, and sleep disturbances, is linked to increased diabetes distress.
July 25, 2025
A recent study has suggested the efficacy of a common type 2 diabetes treatment in improving cardiac structure and metabolic control.
Video
Li and Shao discussed the T2D risk reduction seen over the course of the VA MOVE! lifestyle intervention program for veterans.
